# Hemodynamic Study of Avanafil and Two α-Adrenergic Blockers,Doxazosin and Tamsulosin

> **NCT01100021** · PHASE1 · COMPLETED · sponsor: **VIVUS LLC** · enrollment: 48 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Tamsulosin and avanafil
- **DRUG:** Doxazosin and avanafil

## Key facts

- **NCT ID:** NCT01100021
- **Lead sponsor:** VIVUS LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-03
- **Final completion:** 2010-04
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2011-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01100021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01100021, "Hemodynamic Study of Avanafil and Two α-Adrenergic Blockers,Doxazosin and Tamsulosin". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01100021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*